Privia Health Group Inc(PRVA)

upturn advisory logo
ADVISORIES YOU CAN VERIFY
QUALITY SIGNAL
1-STAR RATING
PASS
LAST CLOSE
$19.87
09/28/2026
(24-hour delay)

Advisory History & Simulated Performance *

*as per simulation (see disclosures)
  • ALL
  • 1Y
  • 1M
  • 1W
  • BUY Advisory
  • SELL Advisory (Profit)
  • SELL Advisory (Loss)
  • Profit
  • Loss
  • PASS (Skip)
Upturn Stock price based on last close iconStock price based on last close

Advisory Performance History (Simulated)Advisory Performance History info

Upturn Advisory & Investor View for PRVA

09/28/2026: PRVA (1-star) is currently NOT-A-BUY. Pass it for now.

Privia Health Group Inc is a technology-enabled physician enablement company that helps independent doctors transition to value-based care models. The company has a leading position in supporting fragmented physician groups, allowing them to remain independent while achieving the scale needed for modern care delivery. Its primary growth opportunity lies in the continued national expansion of its platform and deeper participation in risk-sharing contracts. However, investors must weigh these opportunities against potential regulatory changes in healthcare reimbursement and intensifying competition from large-scale retail entrants. The stock best suits growth-oriented investors interested in healthcare disruption, who should monitor long-term physician retention and the company’s ability to manage costs within its risk-based contracts.

How to Read the Upturn Advisory

The Upturn Star Rating and the current BUY, SELL, or PASS advisory are generated by Upturn’s AI advisory engine based on proprietary signal analysis, price behavior, advisory history, and historical signal performance.

Company fundamentals, valuation, risks, and news provide supporting context about the business.

Investor Fit

Investor styleFitWhy
Growth investorStrong fitThe company operates in the high-growth value-based care sector, focusing on capturing market share in the fragmented physician market.
Momentum investorMixed fitThe stock's performance is often tied to market sentiment regarding healthcare policy and the broader adoption of value-based care.
Value investorWeak fitThe company is currently prioritized for growth rather than traditional value metrics like dividends or low P/E multiples.
Dividend investorWeak fitPrivia Health does not pay a dividend as it reinvests all cash flow into growth initiatives.
Low-risk investorWeak fitThe company is subject to high volatility typical of healthcare technology growth stocks and regulatory uncertainty.

Risk Profile

Risk factorLevelWhy it matters
Price volatilityHighThe stock price is susceptible to swings based on shifts in healthcare reimbursement trends.
Valuation riskMedium / highGrowth expectations are already priced in, leaving little room for error if expansion targets are missed.
Competition risk (value-based care)Medium / highIncreased competition from well-capitalized retailers could pressure margins.
Business qualityMediumThe business model is sound but highly dependent on the success of individual provider partnerships.
Dividend incomeLow / noneInvestors should not expect income generation from this stock.
Execution riskMediumScaling operations across diverse state regulations requires significant operational discipline.

Price Behavior

Downtrend
PRICE PATH

Downtrend

The stock has experienced a sustained decline in price over recent periods.

Moderately Choppy
PRICE STABILITY

Moderately Choppy

The stock has experienced noticeable price swings while retaining some directional structure.

Analysis of Past Performance

Type Stock
Historic Profit -24.14%
Avg. Invested days 29
Today’s Advisory PASS
Upturn Advisory Rating upturn star rating icon
Upturn Advisory Performance Upturn Advisory Performance icon 2.0
Stock Returns Performance Upturn Returns Performance icon 1.0
Upturn Profits based on simulation icon Profits based on simulation
Upturn last close icon Last Close 09/28/2026

Upturn Scorecard

Upturn Star Rating

★★★★★
PRVA receives a 3-star rating, supported by solid company fundamentals, and strong analyst coverage. The rating is constrained by soft unit economics, and weak price momentum.

Company Fundamentals

★★★★★
PRVA has solid overall fundamentals (4 stars), with moderate financial health, solid growth momentum, and strong ownership. In FY2025 versus FY2024, strong earnings growth (+59.3%) and solid cash generation (FCF margin 7.6%) are partially offset by soft profitability (net margin 1.1%).

Financial Health Rating

★★★★★
PRVA's financial health is supported by solid cash strength, including free-cash-flow generation (7.6% of revenue). Profitability is soft (2 stars), which helps explain the 3-star overall score.

Growth Momentum Score

★★★★★
Earnings growth is PRVA's strongest growth driver at +59.3% FY2025 versus FY2024 (strong, 5 stars). Revenue growth (+22.3%, solid) and free-cash-flow growth (+55.6%, strong) are also constructive, though not equally high across every growth measure.

Ownership

★★★★★
Institutional ownership is 98.5% and approximately 85.3% of outstanding shares are publicly tradable, supporting liquidity and institutional participation. Insider ownership of 6.19% supports management-shareholder alignment.

Top 5 Institutional Investors

BlackRock Inc 14.92%
FMR Inc 10.21%
Durable Capital Partners LP 9.11%
Vanguard Portfolio Management, LLC 4.92%
Rubicon Founders LLC 4.66%

Unit Economics (Per $1K Revenue)

★★★★★
PRVA generates approximately $99 of gross profit, $16 of operating income, and $76 of free cash flow for every $1,000 of revenue. Based on FY2025 results. Weak margins explain the 2-star rating, with solid cash conversion and moderate capital efficiency.

Economic Dimensions

★★★★★
Effective Tax Rate: 32.35%

Quantitative Style Profile

★★★★★
PRVA has a liquid profile. Weak momentum is the primary drawback, while valuation that is moderately attractive rather than deeply discounted.

Style Classification

Quality Focused

Small / Mid Cap RiskShort Squeeze RiskHighly Liquid / Institution-Friendly

Key Highlights

Company Size Mid-Cap Stock
Market Capitalization 2.52B USD
Price to earnings Ratio 89.59
1Y Target Price 31.47
Price to earnings Ratio 89.59
1Y Target Price 31.47
Volume (30-day avg) 1.2M shares
Beta 0.88
52 Weeks Range 18.91 - 28.82
Updated Date 09/27/2026
52 Weeks Range 18.91 - 28.82
Updated Date 09/27/2026
Dividends yield (FY) -
Basic EPS (TTM) 0.22

How Company Makes Money

Business areaWhat it includesRetail investor read
Platform ServicesPractice management fees, care coordination, and administrative support services for independent providers.The company earns revenue by acting as a 'business-in-a-box' for doctors, charging fees to help them operate more efficiently.
Value-Based ContractsPerformance-based bonuses and shared savings payments derived from managing total healthcare costs.Privia makes money when the doctors in its network successfully keep their patients healthy while lowering total medical costs.

Analyzing Revenue: Products, Geography and Growth

Revenue by Products

Product revenue - Year on Year

Advertisement

Valuation

Trailing PE 89.59
Forward PE 17.27
Enterprise Value 2.04B
Price to Sales(TTM) 1.07
Enterprise Value 2.04B
Price to Sales(TTM) 1.07
Enterprise Value to Revenue 0.86
Enterprise Value to EBITDA 35.76
Shares Outstanding 127.73M
Shares Floating 108.95M
Shares Outstanding 127.73M
Shares Floating 108.95M
Percent Insiders 6.19
Percent Institutions 98.53

Icon representing Upturn AI-generated SWOT analysis summary Upturn AI Summary

Information icon for Upturn AI Summarization accuracy disclaimer AI Summarization is directionally correct and might not be accurate.

Information icon for Upturn AI Summarization data freshness disclaimer Summarized information shown could be a few years old and not current.

Information icon warning about Upturn AI Fundamental Rating based on potentially old data Fundamental Rating based on AI could be based on old data.

Information icon warning about potential inaccuracies or hallucinations in Upturn AI-generated summaries AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.

Financial Metrics

🧭 Investment Snapshot

Total Revenue (Scale)

Information icon Total money earned from selling products or services before any costs. It is needed to understand the scale of the business and its ability to generate income.

Net Income (Profit)

Information icon Final profit after all expenses, interest, and taxes are deducted. It is needed to determine the overall profitability available to shareholders.

Free Cash Flow (Cash Strength)

Information icon Cash remaining after operating activities and capital expenditures, showing cash available for growth. It is needed to evaluate the company’s ability to invest, pay dividends, or reduce debt.

📈 Growth & Strength

Operating Income (Core Profit)

Information icon Profit from core operations after deducting all operating expenses. It is needed to measure how efficiently the company runs its primary business activities.

EBITDA (Cash Earnings)

Information icon Earnings before interest, taxes, depreciation, and amortization, indicating operating cash potential. It is needed to compare operating performance across companies without accounting or financing differences.

Gross Profit (Unit Profitability)

Information icon Revenue minus cost of revenue, showing profit after direct production costs. It is needed to evaluate core business profitability before overhead expenses.

🛡️ Financial Safety

Cash (Liquidity Buffer)

Information icon Total cash and cash equivalents on hand. It is needed to evaluate immediate liquidity and financial flexibility.

Total Debt (Leverage Risk)

Information icon Total debt including both short-term and long-term components. It is needed to assess the company’s leverage and financial risk.

Net Working Capital (Short-Term Health)

Information icon Current assets minus current liabilities, indicating short-term liquidity strength. It is needed to assess whether the company can meet its short-term obligations.

🧱 Balance Sheet Strength

Stockholder Equity (Net Worth)

Information icon Total equity value held by shareholders. It is needed to understand the net worth of the company from the owners’ perspective.

Total Assets (Asset Base)

Information icon The full value of everything the company owns, including cash, inventory, equipment, and investments. It is needed to understand the resource base used to generate revenue.

Income Before Tax (Pre-Tax Earnings)

Information icon Income before provision for income taxes. It is needed to analyze profitability independent of tax structures.

⚙️ Cost & Drag Factors

Cost of Revenue (Production Cost)

Information icon Direct costs required to produce and deliver the products or services sold. It is needed to assess efficiency in production and service delivery.

Total Operating Expenses (Operating Cost)

Information icon Indirect costs of running the business such as salaries, marketing, and administration. It is needed to understand how much it costs to sustain ongoing business operations.

Income Tax Expense (Tax Drag)

Information icon Amount of taxes paid or payable to the government. It is needed to evaluate the impact of taxation on overall profitability.

About Privia Health Group Inc

Exchange NASDAQ
Headquarters Arlington, VA, United States
IPO Launch date 2021-04-28
CEO & Director Mr. Parth Mehrotra
Sector Healthcare
Industry Health Information Services
Full time employees 1226
Full time employees 1226

Privia Health Group, Inc. operates as a national physician-enablement company in the United States. The company collaborates with physician practices, health plans, and health systems. It also offers technology and population health tools to enhance providers' workflows; management services organization that enable providers to focus on their patients by reducing administrative work; and single-TIN medical group that facilitates negotiating power, clinical integration, and alignment of financial incentives. In addition, the company operates accountable care organization, which engages patients, reduce inappropriate utilization, and enhance coordination and patient quality metrics to drive value-based care; and network for purchasers and payers that enable providers to connect across platform to better understand the holistic needs of each patient and connect with other providers to address individual medical needs. The company was founded in 2007 and is headquartered in Arlington, Virginia.